https://www.timesofisrael.com/pfizer-boss-albert-bourla-receives-1-million-genesis-prize-in-jerusalem/

Pfizer boss Bourla receives $1M. Genesis Prize, pledges funds for Holocaust museum

Protesting anti-vaxxers greet hundreds of guests at star-studded Jerusalem event; Bourla, son of Greek survivors, to give cash to planned Holocaust Museum in Thessaloniki

Albert Bourla, the CEO and chairman of Pfizer, accepted this year’s annual $1 million Genesis Prize in Jerusalem on Wednesday evening, announcing that he would donate the funds towards a planned Holocaust Museum in Thessaloniki, Greece, where he was born.

Bourla, the son of Holocaust survivors, led his company to develop the Pfizer-BioNTech vaccine against COVID-19 in just nine months.

Nearly 20 million lives were estimated to be saved by COVID-19 vaccines during the first year they became available.

The annual prize, awarded since 2014, is given to “extraordinary individuals for their outstanding professional achievement, contribution to humanity, and commitment to Jewish values.”

At a glittering ceremony attended by around 900 guests, including President Isaac Herzog and his wife, Michal, Bourla recalled his parents, among just 2,000 survivors of the Holocaust among a prewar Jewish population in the city of 50,000.

He credited his mother Sara, who was saved from a firing squad by a bribe seconds before she was due to be shot, for influencing his life’s path by always insisting that nothing was impossible.

Lauding Bourla for his achievements, Herzog said: “He was not deterred by high stakes, by naysayers, by conspiracy or by politics. He believed in the vaccine and invested every ounce of himself in realizing what seemed at the time a far-fetched fantasy. The vaccine was developed in record speed, utilizing the technology of tomorrow to successfully hold back a devastating pandemic.”

Israel was one of the first countries to vaccinate its population against COVID-19, using Pfizer’s shot.

Noting his pride in being both a Jew and a citizen of Greece, Bourla thanked Israel, which he first visited 45 years ago, for providing his company with extensive data about the safety of the vaccine.

The Genesis Philanthropy Group was co-founded ten years ago by Ukraine-born oligarchs Mikhail Fridman and German Khan, and Russian-born Petr Aven. It provided a permanent endowment of $100 million to establish the Genesis Prize Foundation.

All three men stepped down from the Genesis Philanthropy Group’s board in March after being slapped with Western sanctions for their links to Russian President Vladimir Putin after the Russian invasion of Ukraine.

A spokesperson for the Genesis Prize Foundation stressed that GPF was a “fully independent Israeli public benefit company” and that “sanctioned individuals or entities” played no part in it.

Dozens of protesters — many of them anti-vaxxers — gathered outside the Jerusalem Theater to protest the honoring of Bourla and the use of oligarch money for this year’s prize.

pt1

>>16954992

Part of a photo montage presented during the Genesis Prize award ceremony in Jerusalem, showing the devastation in Ukraine caused by the Russian invasion, June 29, 2022. (Sue Surkes/Times of Israel)

Inside, the ceremony began by acknowledging the “pain and suffering of the Ukrainian people,” and showing an extensive photo montage of the destruction being wreaked by the Russian invasion of that country.

The event, hosted by “Suits” actress Sarah Rafferty, featured Israeli singers Yehuda Poliker — himself the son of Holocaust survivors from Thessaloniki — and Shiri Maimon.

2 of 2

https://twitter.com/theflowernurse/status/1552996193172602886/photo/1

Chitin

>>16955002

https://twitter.com/LeylaRostami/status/1554561803283226627

LEILA

@LeylaRostami

Insect burgers in Germany…

(2018)

Bug appetite: German supermarket sells insect burgers

https://www.theguardian.com/world/2018/apr/22/bug-appetite-german-supermarket-sells-burgers-made-from-worms

https://www.breitbart.com/europe/2022/08/02/jeff-bezos-megayacht-forced-to-flee-in-middle-of-night-to-escape-egging-from-locals/

Jeff Bezos’ Megayacht Forced to Flee in Middle of Night to Escape Egging from Locals

The controversial megayacht of Amazon’s climate-crazy boss Jeff Bezos appears to have avoided an egging while sneaking through Rotterdam.

The incomplete megayacht of Amazon tsar and notorious climate crazy Jeff Bezos appears to have managed to sneak through Rotterdam last night without being egged, despite having drummed up massive controversy over plans to dismantle a city landmark to get the huge craft out to sea earlier this year.

Soon to be the largest megayacht ever built, the vessel earned the ire of local Rotterdammers after it was announced that a historic bridge would have to be partially dismantled to allow the ship built in a local yard to reach the sea due to the ship’s abnormally large masts, with many locals threatening to egg the vessel as it travelled through the city.

While this plan was subsequently dropped, according to a report by specialist website Schuttevaer, it appears that significant care was nevertheless taken to transport the vessel without upsetting the locals, with the incomplete ship reportedly taking an unusual, longer route to another shipyard, piquing the interests of enthusiasts.

Oceanco launched the 127m/ 417ft three-masted schooner Y721 early this morning. The yacht left the shipyard in Alblasserdam for Rotterdam directly after her launch. Photos by @DutchYachting.

#jeffbezos #y721 #amazon #oceanco #superyacht #megayacht #dehef #rotterdam #schooner pic.twitter.com/ngyFfwHrwn

— Dutch Yachting (@Dutchyachting) August 2, 2022

The vessel is also reported to have started its journey at 3am, traversing through the dead of night to reach the Greenport Rotterdam Shipyard, where it is due to be completed.

People filming the unfinished ship’s maiden voyage meanwhile describe having searchlights aimed at them by workers, seemingly in an attempt to prevent them from filming or taking pictures.

“When I was standing on one of the bridges, they shined a searchlight on me, so it wasn’t easy for me to take pictures,” Der Spiegel reports one enthusiast as saying, who speculated that the strange route the ship took, as well as the time of the transfer, were both intentional to avoid pictures being taken of the vessel.

Historic Steel Bridge to be Dismantled Because it’s too Small for Bezos Superyacht to Passhttps://t.co/imuvCCbmQq

— Breitbart London (@BreitbartLondon) February 4, 2022

Also notable about reporting surrounding the launch of Bezos’ superyacht is that it seemingly appears to have avoided being egged by protesters, something that might have been at least partially avoided — despite previous threats — due to the time of the transfer.

This is also perhaps partly due to the fact that the ship avoided going near Rotterdam’s city centre entirely, despite initial plans involving the ship taking such a route, and even requiring the city’s famous Hef bridge to be dismantled so that the 130ft tall ship could pass through.

“Calling all Rotterdammers, take a box of (rotten) eggs with you and let’s throw them en masse at Jeff’s superyacht when it sails through the Hef in Rotterdam,” a Facebook event page advertising the protest previously read.

“Rotterdam was built from the rubble by the people of Rotterdam, and we don’t just take that apart for the phallus symbol of a megalomaniac billionaire,” it continued. “Not without a fight!”

Meanwhile, despite making various pronouncements about climate change, Bezos’ crowning jewel, Amazon, has seen its carbon emissions spike in 2021, growing by nearly one-fifth over 2020.

This is on top of a previous 40 per cent rise in emissions between 2019 and 2020, something that was seemingly brought about by the company’s surging business during COVID-19.

https://twitter.com/DavidInglesTV/status/1554619778111016961

David Ingles

@DavidInglesTV

JUST IN: China halts natural sand shipments to Taiwan

This may affect silicone chip processing, yes?

https://iceni.substack.com/p/draco-down-the-memory-hole

DRACO Down the Memory Hole

They had a cure over a decade ago, but not for you

Spartacus

22 hr ago

Double-stranded RNA Activated Caspase Oligomerizer

On July 27th, 2011, a paper was published in PLOS ONE describing a novel protein biologic antiviral. It was called DRACO, an acronym for Double-stranded RNA Activated Caspase Oligomerizer.

PLOS - Broad-Spectrum Antiviral Therapeutics

Currently there are relatively few antiviral therapeutics, and most which do exist are highly pathogen-specific or have other disadvantages. We have developed a new broad-spectrum antiviral approach, dubbed Double-stranded RNA (dsRNA) Activated Caspase Oligomerizer (DRACO) that selectively induces apoptosis in cells containing viral dsRNA, rapidly killing infected cells without harming uninfected cells. We have created DRACOs and shown that they are nontoxic in 11 mammalian cell types and effective against 15 different viruses, including dengue flavivirus, Amapari and Tacaribe arenaviruses, Guama bunyavirus, and H1N1 influenza. We have also demonstrated that DRACOs can rescue mice challenged with H1N1 influenza. DRACOs have the potential to be effective therapeutics or prophylactics for numerous clinical and priority viruses, due to the broad-spectrum sensitivity of the dsRNA detection domain, the potent activity of the apoptosis induction domain, and the novel direct linkage between the two which viruses have never encountered.

…

Funding: This work is funded by grant AI057159 (http://www.niaid.nih.gov/Pages/default.aspx) from the National Institute of Allergy and Infectious Diseases and the New England Regional Center of Excellence for Biodefense and Emerging Infectious Diseases, with previous funding from the Defense Advanced Research Projects Agency, Defense Threat Reduction Agency, and Director of Defense Research & Engineering. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Opinions, interpretations, conclusions, and recommendations are those of the authors and are not necessarily endorsed by the United States government.

This research was performed at MIT’s Draper Labs and was funded by NIAID, DARPA, and DTRA. The Pentagon were after a broad-spectrum antivirus that could cure any viral infection, in case soldiers were exposed to an unknown pathogen for which no vaccine existed (i.e. a biowarfare agent). Dr. Todd Rider’s solution was to come up with a chimeric protein consisting of a dsRNA detection domain fused end-to-end with an apoptosis induction domain. These protein biologics were produced by being cultured in a bioreactor in E. Coli bacteria transfected with plasmids to produce DRACO proteins, similar to how recombinant insulin is produced.

pt 1

>>16955125

It is possible to formulate different types of DRACOs, such as Protein Kinase R and Apoptotic protease activating factor-1, PKR and FADD, RNaseL and Apaf-1, et cetera. DRACOs all have the same mechanism of action. They take advantage of the fact that many viruses, including coronaviruses, produce long strands of dsRNA when they infect cells and replicate. Even viruses with ssRNA genomes like SARS-CoV-2 do this. Healthy cells, on the other hand, don’t have any dsRNA in them at all.

This is how it works:

DRACO proteins are injected into the subject.

The proteins use cell-penetrating peptides (like HIV TAT) to cross cell membranes and enter cells.

If there is no viral dsRNA present, the protein does nothing.

If there is viral dsRNA present, the dsRNA detection domain (such as PKR) binds to the dsRNA.

Multiple DRACOs bind side-by-side to the viral dsRNA.

The exposed apoptosis induction domains of the DRACOs (such as Apaf-1) bind and crosslink procaspases and force the infected cell to self-destruct.

DRACOs are like little protein limpet mines that enter infected cells and command those cells to undergo apoptosis immediately if they find signs of viral infection, but are non-toxic to healthy tissue. This was proven experimentally in mouse models. They injected mice with DRACO, and then injected them with large quantities of influenza virus. Nothing happened to the DRACO treated mice when they were exposed to influenza. They were fine. In fact, they dissected the healthy DRACO-treated mice and confirmed that the DRACO proteins were non-toxic to uninfected cells.

DRACO proteins conferred practically ironclad protection against viruses that lasted up to a week after injection. All viruses. You see, viruses have ways of suppressing apoptosis pathways in cells, turning infected cells into practical zombies that can’t quite eliminate themselves before they replicate tons of viral particles. It makes a real mess. However, a protein that combines a dsRNA detection domain with an apoptosis induction domain completely bypasses the tricks and loopholes that viruses evolved to prevent apoptosis. Viruses don’t see DRACO coming. It completely destroys the cell the moment viral replication starts, shutting down the infection immediately while it’s still in a small population of cells. If DRACO is administered late, there is indeed more apoptosis and more inflammation, due to the larger population of affected cells. If it is administered prophylactically, before infection, viruses can’t even replicate in DRACO-treated cell populations at all, whether in vitro or in vivo. It puts a complete halt to it.

Now, with results like these, the logical thing to do would be to engage in more animal testing, experimentally confirm (or refute) the effects, and, eventually, proceed to human trials. After all, in theory, DRACO could be combined with surveillance and contact tracing to completely arrest the spread of a pathogen before it even had a chance to become a pandemic. If it worked, and if it had minimal side effects, it would have become an invaluable tool in the epidemic control toolbox.

That wasn’t what happened.

pt 2

>>16955128

A Sidelined Cure

In 2014, Todd Rider sought $2 million in additional grant funding from the Templeton Foundation to continue his work. However, during a reorganization at the Templeton Foundation, the grant fell through, and he was left with nothing. Desperate for money, he started a pair of Indiegogo campaigns to fund his research that also failed.

Business Insider - This man's potentially huge medical breakthrough can't get funding, so he's trying something desperate

He launched an Indiegogo campaign on October 13 to raise $100,000, enough to restart his work, though just a fraction of what he truly needs. But after two months, he was only halfway there, so the campaign was recently extended.

It's impossible to know at this early stage if DRACO can do everything that Rider hopes it will — whether it will really be able to seek and destroy a wide variety of viruses inside a sick person.

And now we may never find out.

Around the same time, Ken Gabriel, an ex-DARPA and ex-Google guy, took over as head of MIT’s Draper Labs.

PRWeb - Ken Gabriel, former DARPA, Google Executive, to Lead Draper Laboratory

Gabriel has been a tenured professor in both the Robotics Institute and the Department of Electrical and Computer Engineering at Carnegie Mellon University. He also served as a program manager and office director at DARPA, where he conceived and led projects that took MEMS out of the laboratory into practical applications. Earlier in his career he was a visiting professor at the University of Tokyo, a research scientist at the Naval Research Laboratory and a research principal investigator at AT&T Bell Laboratories. Gabriel’s honors include being named a Technology Pioneer by the World Economic Forum at Davos and named to the Senior Executive Service, and awarded the Carlton Tucker Prize for Excellence in Teaching from the Massachusetts Institute of Technology (MIT). Gabriel holds SM and ScD degrees in Electrical Engineering and Computer Science from the MIT.

Ken Gabriel also has links to the Wellcome Trust, who are right next door to Tavistock and have links to Sequoia Capital. He is the COO of Wellcome Leap.

Wellcome Leap - Wellcome Leap Bolsters Leadership Team, Announces Former President & CEO of Draper Ken Gabriel as Chief Operating Officer

Wellcome Leap (“Leap”), an advanced projects non-profit founded by the Wellcome Trust to accelerate innovations that benefit global human health, today announced that former U.S. Defense Advanced Research Projects Agency (DARPA) acting director Kaigham ‘Ken’ Gabriel has been appointed as Chief Operating Officer (COO) of the organization.

Ken will lead operations at Leap as the organization undertakes bold, unconventional programs and funds them at scale.With initial funding of $300 million, Leap’s programs will target complex human health challenges with the goal of achieving breakthrough scientific and technological solutions within a decade.

“Ken’s rare blend of experience across disciplines and sectors will be key to building Leap globally and delivering on our mission,” said Regina E. Dugan, CEO of Wellcome Leap. “He’s devoted to breakthrough innovation and I’m stoked to work with him.”

pt 3

>>16955134

Whitney Webb has extensive coverage on Wellcome Leap and their transhumanist intentions.

Unlimited Hangout - A “Leap” toward Humanity’s Destruction

A UK nonprofit with ties to global corruption throughout the COVID-19 crisis as well as historical and current ties to the UK eugenics movement launched a global health-focused DARPA equivalent last year. The move went largely unnoticed by both mainstream and independent media.

The Wellcome Trust, which has arguably been second only to Bill Gates in its ability to influence events during the COVID-19 crisis and vaccination campaign, launched its own global equivalent of the Pentagon’s secretive research agency last year, officially to combat the “most pressing health challenges of our time.” Though first conceived of in 2018, this particular Wellcome Trust initiative was spun off from the Trust last May with $300 million in initial funding. It quickly attracted two former DARPA executives, who had previously served in the upper echelons of Silicon Valley, to manage and plan its portfolio of projects.

This global health DARPA, known as Wellcome Leap, seeks to achieve “breakthrough scientific and technological solutions” by or before 2030, with a focus on “complex global health challenges.” The Wellcome Trust is open about how Wellcome Leap will apply the approaches of Silicon Valley and venture capital firms to the health and life science sector. Unsurprisingly, their three current programs are poised to develop incredibly invasive tech-focused, and in some cases overtly transhumanist, medical technologies, including a program exclusively focused on using artificial intelligence (AI), mobile sensors, and wearable brain-mapping tech for children three years old and younger.

Odysee - The "Wellcome Leap" into Transhumanism - Whitney Webb on The Corbett Report

Whitney Webb of UnlimitedHangout.com joins us once again, this time to discuss her latest article, "A “Leap” toward Humanity’s Destruction." Even if you're familiar with the transhumanist agenda, what the ex-DARPA, ex-Silicon Valley old hands at the newly created Wellcome Leap are planning to do in their quest to transform the human species in the coming decade will blow your mind.

Everything ties right back into the same WEF/Club of Rome/Rockefeller transhumanist agenda; human augmentation, cattle-tagging and tracking people, pulling health data right out of their bodies, using brain data for precrime, manipulating people remotely, et cetera.

The Overclass want people to be brought onto the so-called Internet of Bodies, whether we like it or not. Mandatory vaccination is just an excuse. What they really want is unlimited leeway to mandate injections of anything, using pandemic viruses as a pretense.

It is worth reminding readers that DARPA are working on a nanoparticle-based BCI that could be used for mind control, and that this technology is advancing rapidly.

Rice University - Wireless activation of targeted brain circuits in less than one second

The researchers used genetic engineering to express a special heat-sensitive ion channel in neurons that cause flies to partially spread their wings, a common mating gesture. The researchers then injected magnetic nanoparticles that could be heated with an applied magnetic field. An overhead camera watched flies as they roamed freely about an enclosure atop an electromagnet. By changing the magnet’s field in a specified way, the researchers could heat the nanoparticles and activate the neurons. An analysis of video from the experiments showed flies with the genetic modifications assumed the wing-spread posture within approximately half a second of the magnetic field change.

Robinson said the ability to activate genetically targeted cells at precise times could be a powerful tool for studying the brain, treating disease and developing direct brain-machine communication technology.

pt 4

>>16955136

You can’t have technology like this without a legal and civil rights framework that accounts for it, because it opens the public up to hideous abuse.

Ethicists are already very deeply concerned about the implications of neurotechnology. That’s why Rafael Yuste, the scientist whose work inspired DARPA’s BRAIN Initiative, started the Neurorights Foundation:

Neurorights Foundation

Jonathan Moreno is very concerned about the weaponization of neurotechnology. He wrote a book in 2012 entitled Mind Wars: Brain Science and the Military in the 21st Century. He also wrote an article on the matter that was republished in the Bulletin of the Atomic Scientists:

Bulletin of the Atomic Scientists - When neuroscience leads to neuroweapons

International law strongly proscribes the use of neuroweapons, which target the brain and central nervous system and can be chemical, biological, or toxin-producing in nature. The CWC bans the production, acquisition, stockpiling, retention, and use of chemical weapons. This relatively straightforward prohibition is undercut, however, by the convention’s provision allowing chemical agents to be used for certain law enforcement activities, like riot control. The BTWC is more sweeping in its prohibition: It bans biological agents or toxins from being used as weapons, whatever their mode or method of production. But unlike the CWC, the BTWC has no mechanism for inspecting national facilities to determine whether the prohibition is being upheld.

Neuroweapons, thus, present a challenge for both the CWC, because of its limited scope, and the BTWC, because of its lack of an inspection mechanism. In light of these limitations, it would not be surprising to see governments turn to exotic incapacitating agents in the coming decade, in an attempt to strengthen their ability to respond to threats that are unconventional, mobile, or embedded within civilian populations. Some of these neuroweapon users may be autocratic regimes interested in repressing dissent or rebellion, but as we’ve seen, the militaries of rich, democratic nations also have an interest in using nonlethal chemical weapons in attempting to confront insurgents or terrorist groups.

Attempting to counter the threat of terrorism without harming noncombatants is arguably a well-placed intention, but it paves a road to hell by threatening to undermine almost half a century of work to keep the global community engaged in upholding the ban on biological weapons, and the hard-won (if incomplete) destruction of chemical weapons stockpiles around the world. Facilities that can create nonlethal biochemical agents aren’t too different from ones that can create lethal agents—and may be identical if the only difference between a lethal and nonlethal weapon is dose.

When we bring up things like the N3 program, we’re talking about the tech to strip basic autonomy and rights from billions of people overnight and unironically turn them into Borg drones.

No, that’s not hyperbole or comical exaggeration. When I say Borg drones, I mean Borg drones.

pt 5

>>16955142

Again, as I stated in previous articles on recent advances in biotechnology, the Chemical Weapons Convention and Biological Weapons Convention do not bar research into mind control neurotech. All you need is a bioethicist who will sign off on a project and say that it’s neither killing nor incapacitating, and therefore is not a proscribed toxin or agent.

Laws and treaties have not kept up with the pace of technological advancement in this area at all.

DRACO Returns

Rick Kiessig is the Director and CEO of the New Zealand company Kimer Med, a startup focused on reviving the DRACO concept for consumer use. He believes that pharmaceutical companies have avoided developing DRACO because it would cannibalize sales from their other, more lucrative products.

Lifespan - Rick Kiessig Discusses VTose, a Broad-Spectrum Antiviral

Dr. Todd Rider, the inventor of DRACO, said he found that government grant and NIH-type funding related to pharmaceuticals is largely limited to two broad areas: either basic research or the final step of bringing a new drug to market. However, they apparently don’t like to fund the middle part (where we are now), which involves clinical trials.

He also felt that investment from pharma companies would require showing effectiveness against commercially interesting viruses, such as herpes, which is why that was one of the goals of his 2015/2016 crowdfunding campaigns.

My view is a bit more cynical. Pharma companies have a number of drugs to treat viral illness (antivirals and others). Many of those drugs require regular use for a long period of time, because they don’t make the virus go away, they just temporarily keep the symptoms at bay as long as you continue to take them.

Grim Conclusion

If you’ve been following along with our prior articles, you’d know that NIH, USAID, and DTRA are complicit in harming Americans due to their funding for EcoHealth Alliance and their GOF research which undoubtedly led to the creation of SARS-CoV-2. They also funded DRACO, but mysteriously abandoned it after it was proven to work.

One can only speculate, but from where I stand, it looks like they wanted an antidote to their forthcoming SARS-based bioweapon. Something for VIPs and officials to use in secret, while leaving the public to rot and die, suffering from long-term sequelae from COVID-19 or the side effects from the barely tested, highly toxic, autoimmunity-inducing vaccines.

It would be trivial to clandestinely produce DRACO in sufficient quantities for VIPs to use. All you need is a couple bioreactors, some chromatography columns, some E. Coli, and the DRACO plasmids to transfect into them before culturing. It’s basically all the same lab equipment needed to produce recombinant insulin. This equipment could be hidden in the corner of a bunker or a nondescript commercial building, occupying no more than several hundred square feet at the most. Huge batches sufficient for thousands of people could be manufactured even in a relatively small laboratory.

We know for a fact that DRACO is being synthesized in China, where there is ongoing research into its effectiveness in porcine reproductive and respiratory syndrome virus.

Elsevier - A high-throughput screen for genes essential for PRRSV infection using a piggyBac-based system

pt 6

>>16955143

Double-stranded RNA activated caspase oligomerizer (DRACO) is a synthetic protein that includes three parts: protein kinase R (PKR 1–181), which can detect dsRNA; apoptotic protease-activating factor 11–97 (Apaf 11-97), which can help to selectively induce apoptosis in cells containing viral dsRNA; and protein transduction domain 4 (PTD-4), which can help to transport proteins into cells (Guo et al., 2015). In short, DRACO can rapidly kill virus-infected cells but does not affect uninfected cells. The DNA elements encoding DRACO were synthesized by General Biosystems (Anhui, China) and cloned into the expression vector pET-28a (+). The recombinant pET-28a-DRACO plasmid was identified by PCR, restriction enzyme digestion and sequencing. Then, the DRACO protein was successfully expressed and purified in vitro.

They had the cure long before they unleashed COVID-19 on us.

Not natural zoonosis. Not a lab leak. Intentional crimes against humanity.

-Spartacus

7 of 7

https://mobile.twitter.com/PeterHotez/status/1554122409237676032

Prof Peter Hotez MD PhD

@PeterHotez

I worry about widespread persecutions against US scientists from the extremists in the US Congress. The midterms should not be viewed as a hunting license vs American scientists. I hope our professional and scientific societies have a plan?

another canadian doctor

https://mobile.twitter.com/infobot13/status/1553453368269586432

Spike Protein

@infobot13

Celebrating life of Dr. Baharan Behzadizad | Chuffed | Non-profit charity and social enterprise fundraisin

⁦

@candacenayman

⁩ why are young healthy Canadian docs dying?

Pfizer papers now searchable

https://mobile.twitter.com/redpill4me/status/1554542139522129921

🇨🇦🇳🇱🇮🇹🇱🇰🇵🇱A Very Private Gentleman

@redpill4me

Search the latest #Pfizerpapers with Abstractor and

@DailyClout

. We have all 259 pdfs (82k pages!) and 9M rows of clinical trial data (see: 'Trace a Trialist') with much more to come.

Abstractor - A search engine for #pfizerdocuments

https://vaccines.shinyapps.io/abstractor/

https://www.godlikeproductions.com/forum1/message5199498/pg1

What will be the result when China ends production and shipping of SSRIs?

>>16955253

>>16955157

>Peter Hotez

Peter Jay Hotez (born May 5, 1958) is an American scientist, pediatrician, and advocate in the fields of global health, vaccinology, and neglected tropical disease control. He serves as founding dean of the National School of Tropical Medicine, Professor of Pediatrics and Molecular Virology & Microbiology at Baylor College of Medicine, where he is also Director of the Texas Children's Hospital Center for Vaccine Development and Texas Children's Hospital Endowed Chair in Tropical Pediatrics, and University Professor of Biology at Baylor College of Medicine. Hotez served previously as president of the American Society of Tropical Medicine and Hygiene and is a founding Editor-in-Chief of PLOS Neglected Tropical Diseases. He is also the co-director ofParasites Without Borders, a global nonprofit organization with a focus on those suffering from parasitic diseases in subtropical environments.

Hotez was born in Hartford, Connecticut, to a Jewish family. His father Edward J. Hotez was a World War II veteran in the United States Navy. Growing up in West Hartford, Hotez graduated from Hall High School in West Hartford. He received a BA in molecular biophysics and biochemistry magna cum laude (Phi Beta Kappa) from Yale University in 1980, a PhD from Rockefeller University in 1986, and a Doctorate in Medicine from Weill Cornell Medical College in 1987. His doctoral dissertation and postdoctoral training were in the areas of hookworm molecular pathogenesis and vaccine development.

Hotez was awarded postdoctoral positions in molecular parasitology and pediatric infectious diseases at Yale University School of Medicine, where he subsequently became an assistant professor in 1992 and an associate professor in 1995. His early research focused on the pathogenesis and molecular mechanisms of human hookworm infection and would eventually lead to a vaccine now in clinical trials, as well as a vaccine against schistosomiasis, also in clinical trials, either of which would be the first successful vaccine for humans to protect against a multi-cellular parasite.

Following the World Health Organization's (WHO) Millennium Development Goals in 2000, Hotez, along with Drs. Alan Fenwick and David Molyneux, led a global effort to rename diseases then being termed simply "other diseases," as "neglected tropical diseases" (NTDs), and promoting the use of therapeutic/preventive chemotherapy through a combination of drugs called the "rapid-impact package."[11] Hotez has advocated for increased efforts to control NTDs since 2005 through publications and speaking engagements, helping to gain increased awareness resulting in a decrease of prevalence and disease burden in many areas.[12]

During these years, Hotez also led the Sabin Vaccine Institute in Washington, DC, as well as efforts to establish PLOS Neglected Tropical Diseases, the first online open access medical journal focused exclusively on neglected tropical diseases.[13]

Vaccine development

In addition to continuing work on vaccines already in clinical trials for hookworm[7] and schistosomiasis,[8] Hotez currently leads a team of researchers developing vaccines against other diseases including leishmaniasis, Chagas disease, SARS, and MERS,[14] and is also working in development of a Coronavirus vaccine.[15] With Maria Elena Bottazzi, he led the team that designed COVID-19 vaccine Corbevax.[16]

COVID-19 response

Hotez has actively used his public profile on Twitter and other social media platforms to help combat misinformation about the COVID-19 pandemic

>>16955294

https://bcmfamily.bcm.edu/2017/04/05/bnai-brith-international-recognizes-dr-peter-hotez-for-distinguished-career/

>>16954992

TheGenesis Philanthropy Groupwas co-founded ten years ago by Ukraine-born oligarchsMikhail Fridman and German Khan, and Russian-born Petr Aven.

>>16955334

>>16955334

>Genesis Philanthropy Group

This is he organization that awarded Genesis to Albert Bourla.

https://christiansfortruth.com/is-rothschild-group-preparing-a-new-updated-protocols-of-zion-for-world-conquest/

This past September, Israeli President Reuven (Ruvi) Rivlin called on Jews of all ages, affiliations and nationalities to discuss, debate and shape the Declaration of Our Common Destiny, a joint project ofGenesis Philanthropy Group(GPG) to allegedly “strengthen the bonds among Jews worldwide”.

The introduction of this draft of the Declaration, and the invitation to Jews of the world engage in a year-long discussion to complete it, are the first steps in a ground-breaking initiative to craft a new Jewish foundational text. The Declaration of Our Common Destiny will be a catalyst for Jews from around the world to come together and deliberate on the values and principles that shape how future generations within Israel and worldwide, relate, empower, and engage with one another across spiritual and cultural identities.

The president began his remarks by thanking those responsible for producing the declaration, and then said, “The miracle of the Jewish people is not only that we survived for thousands of years. The miracle is that, despite the fact that we were spread all over the world, speak different languages and developed different traditions, we always were one people. Despite our differences, we remained bound by our shared history, our core values and beliefs, our Book of Books, and our commitment to improving the world. It helped that our enemies always saw us as one people. Our enemies don’t see any difference between one stream of Judaism and another: Secular, Haredi, Reform, Conservative, Masorti – for them we are all Jews.”

The president continued, saying, “Today, we face a different kind of challenge. Jewish communities around the world have integrated successfully into their home countries. This has created new challenges to Jewish identity and to the Jewish people. The future of the Jewish people depends on three things: preserving our core values, traditions and identity; mutual respect for our differences; and mutual responsibility to each other. We must embrace our unity, and our diversity. We must see our diversity not as a source of weakness, but a source of strength. When I say that the future of the Jewish people depends on preserving our identity, mutual respect, and mutual recognition, I mean also the future of the State of Israel.”

He added, “As a Jewish and Democratic State, Israel is essential for the survival of the Jewish people. And a thriving Jewish people, our fifth tribe, is essential for the survival of the State of Israel. Today is just the start of the journey. From here the Declaration will go on a Jewish “world tour.” It will initiate conversations between communities, streams and generations.”

“If we sincerely embrace our diversity while cherishing our shared history, then this Declaration can serve as a roadmap for the future of the Jewish people,” the president concluded his remarks….

The Declaration of Our Common Destiny is intended to serve as a touchpoint for Jews around the world and as a roadmap for a unified Jewish future….

Rabbi Sharon Brous, Our Common Destiny Scholar from the United States added: “The growing rifts among the Jewish people are not superficial; they are foundational, and they must be honestly and openly addressed. We need more than ever to hear one another despite our differences, and to work together to determine what our shared Jewish inheritance demands of us in this critical time. Though we face great challenges, as a people and as a State, it is my hope that we leave here affirming our commitment to work, unceasingly, in the pursuit of justice, human dignity and peace.”

pt1

>>16955294

>>16955333

>Parasites Without Borders

https://parasiteswithoutborders.com/

they would DEFINATELY know about IVERMECTIN

>>16955377

>>16954992

>>16955570

starting to grasp beliefs are not facts eh?